VON WILLEBRAND DISEASE (VWD)
Clinical trials for VON WILLEBRAND DISEASE (VWD) explained in plain language.
Never miss a new study
Get alerted when new VON WILLEBRAND DISEASE (VWD) trials appear
Sign up with your email to follow new studies for VON WILLEBRAND DISEASE (VWD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study tracks bleeding drug in kids
Disease control Recruiting nowThis study in Japan looks at how safe and effective Vonvendi (rVWF) is for children under 18 with von Willebrand disease, a bleeding disorder. About 13 kids will receive the drug as part of their normal care for bleeding episodes or before surgery. Researchers will monitor side e…
Matched conditions: VON WILLEBRAND DISEASE (VWD)
Sponsor: Takeda • Aim: Disease control
Last updated May 17, 2026 06:59 UTC
-
Lifeline for severe bleeding disorder patients: drug access extended
Disease control AVAILABLEThis program provides ongoing access to an unlicensed treatment called recombinant von Willebrand factor (rVWF) for people with severe von Willebrand disease who have already benefited from it in a previous study. It is for both children and adults who have completed at least 12 …
Matched conditions: VON WILLEBRAND DISEASE (VWD)
Sponsor: Takeda • Aim: Disease control
Last updated May 17, 2026 06:48 UTC
-
New shot aims to stop bleeding in rare blood disorder
Disease control Recruiting nowThis study tests a new medicine called VGA039, given as a shot under the skin, to prevent bleeding episodes in people with von Willebrand disease (VWD). About 60 teens and adults aged 12 to 75 with frequent bleeds will receive the drug and be monitored for safety and how well it …
Matched conditions: VON WILLEBRAND DISEASE (VWD)
Phase: PHASE3 • Sponsor: Vega Therapeutics, Inc • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New hope for bleeding disorder: experimental drug HMB-002 enters human trials
Disease control Recruiting nowThis study tests a new medicine, HMB-002, for people with Von Willebrand disease (types 1 and 2), a bleeding disorder. The trial has two parts: first, a single dose to check safety and how the drug works in the body; second, repeated doses to see if it helps control bleeding. Abo…
Matched conditions: VON WILLEBRAND DISEASE (VWD)
Phase: PHASE1, PHASE2 • Sponsor: Hemab ApS • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
New clotting drug shows promise for rare bleeding disorder in chinese adults
Disease control Recruiting nowThis study tests a drug called VONVENDI (recombinant von Willebrand factor) to see if it is safe and helps control bleeding in Chinese adults with von Willebrand disease (VWD), a condition that makes blood clot poorly. About 20 participants will receive the drug, sometimes with a…
Matched conditions: VON WILLEBRAND DISEASE (VWD)
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
Scientists peek inside blood vessel cells to unravel bleeding disorder
Knowledge-focused Recruiting nowThis study looks at special cells from blood vessels (ECFCs) in people with von Willebrand disease, acquired von Willebrand syndrome, and healthy volunteers. Researchers want to see how these cells make and release a key clotting protein. The goal is to better understand the dise…
Matched conditions: VON WILLEBRAND DISEASE (VWD)
Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Knowledge-focused
Last updated May 17, 2026 06:49 UTC